Health & Aging Brain Clinical Center for Alzheimer's and Memory Health
Official title: HABS-HD - Core C - Clinical Core
Funded at University of North Texas Hlth Sci Ctr · NIH-11173819 · Data updated 2026-11-12
Collecting exams, brain scans, and health information from adults of different racial and ethnic groups to improve prevention and care for Alzheimer's disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas Hlth Sci Ctr NIH-funded |
| Lab location | 1 site (Fort Worth, United States) |
| Project start | September 30, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $15,438,376 |
| NIH project number | 5U19AG078109-04 |
| Project ID | NIH-11173819 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are community-dwelling adults aged 50+ in the existing cohort or adults aged 30–49 being enrolled, especially individuals who identify as African American, Mexican American, or non-Hispanic white and who can attend Fort Worth or partner site visits.
✕Less likely to help
People under 30, those with neurological conditions unrelated to Alzheimer's disease, or those seeking immediate therapeutic effects are unlikely to receive direct personal health benefits from participation.
What this research studies
I would complete interviews, memory and thinking tests, medical exams, brain imaging, and may give blood or other samples as part of regular visits. The study follows people every 24 months and currently includes 3,000 adults aged 50 and older, with plans to enroll 1,500 more adults aged 30–49 across African American, Mexican American, and non-Hispanic white groups. The Clinical Core reviews data to assign research diagnoses and provides feedback to participants, families, and health care providers as part of a community 'give back' approach. Participation helps build a detailed picture of biomarkers and risk across adulthood in diverse communities.
Why it matters
Potential benefit: Could lead to more tailored prevention, diagnosis, and treatment strategies for Alzheimer's disease in diverse racial and ethnic groups.
How similar studies have gone: Large programs like the Alzheimer's Disease Neuroimaging Initiative have advanced biomarker knowledge, but population-specific work focused on African American and Mexican American groups is newer and still emerging.
Where this research is happening
-
University of North Texas Hlth Sci Ctr
Fort Worth, United States Active
Researchers
- Principal investigator: O'bryant, Sid E — University of North Texas Hlth Sci Ctr
- Study coordinator: O'bryant, Sid E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.